Study guide

19.3 Toxicology: Poisoning Recognition & Antidotes

DHA Pharmacist Licensing Assessment PHO5481

Track your progress as you read

Finished sections get a check mark.

1 Exam Overview & Licensing Pathway

1.1 Current Exam Facts & Format 1.2 Eligibility, PQR & the Sheryan Application Process 1.3 Study Strategy & Test-Day Plan

2 Cardiovascular Pharmacology

2.1 Antihypertensives & RAAS Agents 2.2 Heart Failure & Antiarrhythmic Drugs 2.3 Lipid-Lowering & Antianginal Agents

3 Endocrine & Metabolic Pharmacology

3.1 Insulin & Oral Antidiabetic Agents 3.2 Thyroid, Bone & Calcium Agents 3.3 Corticosteroids & Other Hormonal Agents

4 Anti-Infective Pharmacology

4.1 Beta-Lactam Antibiotics 4.2 Non-Beta-Lactam Antibacterials 4.3 Antifungals, Antivirals & Antituberculars

5 CNS, Psychiatric & Pain Pharmacology

5.1 Psychiatric Pharmacology 5.2 Antiepileptics & Neurologic Agents 5.3 Analgesics: NSAIDs, Opioids & Migraine

6 Respiratory, GI & Hematology Pharmacology

6.1 Respiratory Pharmacology 6.2 Gastrointestinal Pharmacology 6.3 Anticoagulants, Antiplatelets & Hematology Agents

7 Pharmaceutical Care: Cardiometabolic Disease

7.1 Diabetes Management & Counseling 7.2 Hypertension & Dyslipidemia Management 7.3 Heart Failure & Anticoagulation Management

8 Pharmaceutical Care: Respiratory, Rheumatology & Infection

8.1 Asthma & COPD Management 8.2 Gout, Pain & Rheumatologic Care 8.3 Infection Management & Antimicrobial Stewardship

9 Counseling, Monitoring & Special Populations

9.1 Patient Counseling, Adherence & Health Literacy 9.2 Therapeutic Monitoring & Laboratory Interpretation 9.3 Pregnancy, Pediatrics, Geriatrics & Organ Impairment 9.4 Pharmacoeconomics & Formulary Decision Making

10 Pharmaceutical Calculations I

10.1 Concentration, Ratio & Percentage Strength 10.2 Weight-Based & BSA Dosing 10.3 Dilution, Concentration & Alligation

11 Pharmaceutical Calculations II

11.1 Infusion Rates & IV Flow Calculations 11.2 Dispensing Quantities & Days' Supply 11.3 Compounding Calculations, Isotonicity & Milliequivalents

12 UAE Pharmacy Law & Regulation

12.1 UAE Regulatory Framework & Licensing Authorities 12.2 Medicine Registration, Pricing & Supply Chain 12.3 Prescription Requirements & Validity

13 Controlled Drugs, Ethics & Pharmacovigilance

13.1 Controlled & Semi-Controlled Medicines in the UAE 13.2 Ethics, Confidentiality & Generic Substitution 13.3 Pharmacovigilance, Recall & Medicine Disposal

14 Pharmacokinetics I: ADME

14.1 Absorption & Bioavailability 14.2 Distribution & Protein Binding 14.3 Metabolism & Elimination

15 Pharmacokinetics II: Kinetics, Dosing & TDM

15.1 Half-Life, Clearance & Kinetic Order 15.2 Loading & Maintenance Dosing 15.3 Therapeutic Drug Monitoring

16 OTC Medicines & Self-Care

16.1 Cough, Cold & Allergic Rhinitis 16.2 GI Self-Care: Heartburn, Constipation & Diarrhoea 16.3 Pain & Fever Self-Care 16.4 Referral Red Flags, Emergency Contraception & Skin

17 Medication Safety

17.1 High-Alert Medications & Error-Prone Abbreviations 17.2 Medication Reconciliation & Duplicate Therapy 17.3 Adverse Drug Reactions & Hypersensitivity Recognition

18 Sterile & Nonsterile Compounding

18.1 Aseptic Technique & Compounding Environments 18.2 Parenteral, TPN & Cytotoxic Preparation 18.3 Nonsterile Compounding

19 Pharmaceutics, Biopharmaceutics & Toxicology

19.1 Dosage Form Design & the Biopharmaceutics Classification System 19.2 Dissolution & Excipients 19.3 Toxicology: Poisoning Recognition & Antidotes

20 Infection Control, Natural Products, Medicinal Chemistry & Pharmacogenomics

20.1 Infection Control & Immunization 20.2 Pharmacognosy & Dietary Supplements 20.3 Medicinal Chemistry Essentials 20.4 Clinical Pharmacogenomics

19.3 Toxicology: Poisoning Recognition & Antidotes

Key Takeaways Explain This Topic AI

Initial management of any poisoned patient is supportive and follows ABCs (airway, breathing, circulation) before decontamination or antidotes; an antidote is never a substitute for securing the airway and correcting hypoxia.

Activated charcoal (1 g/kg, ideally within 1 hour of ingestion) adsorbs many drugs but is contraindicated for acids, alkalis, metals (including lithium and iron), and whenever the airway is unprotected or consciousness is depressed without prior intubation.

Organophosphate poisoning produces a cholinergic crisis (SLUDGE plus miosis and muscle fasciculations); treat with atropine for muscarinic symptoms and pralidoxime chloride to reactivate acetylcholinesterase.

Paracetamol (acetaminophen) hepatotoxicity is caused by NAPQI, which depletes glutathione; N-acetylcysteine replenishes glutathione and is indicated using the Rumack-Matthew nomogram (4-24 h post-ingestion, treat if level >150 µg/mL at 4 h) or if there is any evidence of hepatotoxicity.

Tricyclic antidepressant cardiotoxicity (QRS widening >100 ms, ventricular arrhythmias, hypotension) is treated with intravenous sodium bicarbonate, which alkalinises plasma and blocks fast sodium channels; class Ia/Ic antiarrhythmics are contraindicated because they worsen Na channel blockade.

Last updated: August 2026

General Management of the Poisoned Patient

The first principle of toxicology is supportive care comes first . Before reaching for an antidote, secure the ABCs : protect the airway (intubate if GCS < 8 or the gag reflex is absent), ensure adequate breathing and oxygenation, and support circulation with IV fluids and vasopressors as needed. An antidote is an adjunct, never a substitute for resuscitation.

Decontamination options

Method When to use When NOT to use

Activated charcoal 1 g/kg PO Within 1 hour of ingestion of an adsorbable drug Acids, alkalis (corrosives), metals (lithium, iron, heavy metals) , hydrocarbons; unprotected airway or decreased consciousness without prior intubation; ingestion >1 h ago with delayed-release drugs only

Gastric lavage Within 1 h of a life-threatening ingestion, after airway is secured Corrosives, hydrocarbons (aspiration risk); largely superseded by charcoal for most drugs

Whole bowel irrigation (polyethylene glycol) Iron, lithium , swallowed drug packets ('body packers') Bowel obstruction, ileus, unstable patient

Skin decontamination Cutaneous exposure (organophosphate pesticides, chemical burns) — remove clothing, copious water irrigation

Exam trap: Activated charcoal does not bind lithium, iron, strong acids, alkalis, or hydrocarbons. Giving charcoal for an iron overdose is both useless and may complicate endoscopy. For iron, the answer is whole bowel irrigation plus deferoxamine .

Exam trap: Do not give activated charcoal to a drowsy patient who has not been intubated — the risk is pulmonary aspiration of charcoal, which causes a severe pneumonitis. Secure the airway first, then consider charcoal.

High-Yield Antidote Table

Toxin Toxidrome / clue Antidote Mechanism / key detail

Organophosphates Cholinergic crisis: SLUDGE (salivation, lacrimation, urination, defecation, GI cramps, emesis) + miosis , muscle fasciculations, bradycardia Atropine + pralidoxime (2-PAM) chloride Atropine blocks muscarinic effects; pralidoxime reactivates acetylcholinesterase (must be given early, before the enzyme ages)

Paracetamol (acetaminophen) Initially asymptomatic; 24-72 h later AST/ALT >1000, RUQ pain, coagulopathy N-acetylcysteine (NAC) Replenishes glutathione , detoxifies NAPQI ; use Rumack-Matthew nomogram from 4-24 h post-ingestion; treat if paracetamol level >150 µg/mL at 4 h (or any hepatotoxicity)

Opioids (morphine, heroin, fentanyl) Respiratory depression , sedation, miosis ('pinpoint pupils'), hypotension Naloxone 0.4-2 mg IV/IM, repeat as needed Competitive μ-opioid antagonist; short half-life (30-90 min) so re-dosing or infusion may be needed for long-acting opioids

Tricyclic antidepressants QRS widening >100 ms , ventricular arrhythmias, hypotension, anticholinergic signs (mydriasis, urinary retention) IV sodium bicarbonate Alkalinises plasma (pH 7.45-7.55) and blocks fast Na channels; avoid class Ia/Ic antiarrhythmics (procainamide, quinidine, flecainide) which worsen blockade

Benzodiazepines Sedation, ataxia; rarely life-threatening alone Flumazenil Competitive GABA-A antagonist; caution : can precipitate seizures in chronic users or mixed overdoses with proconvulsants

Digoxin Nausea, vomiting, visual disturbances (yellow-green halos), arrhythmias, hyperkalaemia Digoxin-specific Fab antibody fragments (Digibind/DigiFab) Bind digoxin in plasma; indicated for life-threatening arrhythmia, K > 5 mmol/L, or massive ingestion

Warfarin Elevated INR, bleeding Vitamin K (phytomenadione); PCC for major bleeding Replenishes vitamin K-dependent clotting factors; PCC (prothrombin complex concentrate) acts fastest for life-threatening haemorrhage

Heparin (unfractionated) Bleeding, prolonged aPTT Protamine sulfate Binds heparin; 1 mg neutralises ~100 units of UFH; partial effect against LMWH

Iron Vomiting, GI bleeding, shock, metabolic acidosis Deferoxamine (desferrioxamine) Chelates iron; indicated for significant iron ingestion with symptoms or serum iron > expected toxic level

Methanol / ethylene glycol Visual disturbance (methanol), renal failure (ethylene glycol), severe metabolic acidosis with anion gap Fomepizole (or IV ethanol) ± haemodialysis Inhibits alcohol dehydrogenase, preventing formation of toxic metabolites (formic acid, oxalic acid); dialysis removes parent alcohol and metabolites

Cyanide Soot in mouth (fire victim), bitter almond smell, rapid collapse, metabolic acidosis with high lactate Hydroxocobalamin (preferred) or sodium thiosulfate ± amyl nitrite Hydroxocobalamin binds cyanide to form cyanocobalamin (vitamin B12); thiosulfate donates sulfur to convert cyanide to thiocyanate

Beta-blockers Bradycardia, hypotension, hypoglycaemia, AV block Calcium chloride (or gluconate), glucagon Calcium overcomes channel blockade; glucagon increases cAMP independent of β-receptors

Calcium channel blockers Bradycardia, hypotension, hyperglycaemia (paradoxical) Calcium chloride , glucagon , high-dose insulin euglycaemic therapy (HIET) HIET shifts myocardial metabolism to carbohydrates and improves contractility; often the most effective intervention for severe CCB poisoning

Recognition Patterns and Exam Traps

Pinpoint (constricted) pupils appear in both opioid and organophosphate poisoning. Distinguish by context: organophosphates add profuse secretions (SLUDGE) and muscle weakness; opioids add respiratory depression and a history of IV drug use or fentanyl exposure. The antidotes differ: naloxone for opioids, atropine plus pralidoxime for organophosphates.

Dilated pupils (mydriasis) feature in TCA and anticholinergic (atropine, antihistamine) overdose. TCAs add cardiotoxicity (QRS widening) and require sodium bicarbonate, not physostigmine.

Anion-gap metabolic acidosis in an overdose context points to methanol or ethylene glycol (treat with fomepizole), iron , paracetamol (late), salicylates , and ethylene glycol . The 'MUDPILES' mnemonic (Methanol, Uraemia, DKA, Paraldehyde/Propylene glycol, Iron/INH, Lactic acidosis, Ethylene glycol, Salicylates) still circulates.

Sodium bicarbonate appears in two overdose scenarios on the exam: TCA cardiotoxicity (QRS widening, arrhythmias) and salicylate toxicity (alkalinise urine to trap salicylate ions). Know which clinical setting the question describes.

Flumazenil is contraindicated in patients with a history of seizures or in mixed overdoses involving proconvulsant drugs (e.g. TCAs) because it can precipitate refractory seizures.

N-acetylcysteine is most effective when given within 8 hours of paracetamol ingestion but still benefits patients who present later, even after 24 h, if hepatotoxicity is present; do not withhold NAC because 'the window has passed'.